Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

LIAISON^® Bordetella pertussis Diagnostic Solution

Despite extensive childhood immunization, pertussis remains one of the world’s leading causes of vaccine-preventable deaths. The detection of Bordetella pertussis toxin IgG and IgA helps differentiate between recent Bordetella pertussis infection and late stage of the disease, especially in older children and adults.

LIAISON^® XL

LIAISON^® Bordetella pertussis Toxin IgA

Automated CLIA assay for the quantitative determination of IgA antibodies to Bordetella pertussis toxin in human serum and plasma samples.

LIAISON^® XL

LIAISON^® Bordetella pertussis Toxin IgG

Automated CLIA assay for the quantitative determination of IgG antibodies to Bordetella pertussis toxin in human serum and plasma samples.

Indications for use

Diagnosis

Fully automated solution for Bordetella pertussis toxin IgG and IgA detection

Target patient

Adults and children

Use area

Pediatric medicine, general medicine, respiratory infections

Diasorin’s Simplexa technology for the detection of Bordetella virus

Background

Pertussis, commonly known as whooping cough, is an acute respiratory infectious disease caused by the bacterium Bordetella pertussis. The detection of Bordetella pertussis toxin IgG and IgA is needed to differentiate between recent Bordetella pertussis infection and late stage of the disease, especially in older children and adults, and to aid clinical decisions.

Why use LIAISON^® Bordetella pertussis Diagnostic Solution

A complete automated solution, providing quantitative WHO (World Health Organization) standardized results to aid in the diagnosis of Bordetella pertussis and assess the infection stage.

Complete quantitative solution

Quantitative assays for the detection of Bordetella pertussis Toxin IgG and IgA

Calibration to 1^st WHO international standard

10 – 140 IU/mL Bordetella pertussis Toxin IgG
6 – 100 IU/mL Bordetella pertussis Toxin IgA

Expert Using Diasorin Immunodiagnostics Solutions - Diasorin

To be used on

Designed for both specialty and routine tests, LIAISON^® XL and LIAISON^® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON^® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

LIAISON^® XL

Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.

詳しく調べる

All the products in this family

Discover the range of specialty tests available

Discover more

Please select
your location below

Document repository

Product list

Need more information?

Direct links